Sustained Remissions Following Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) in Patients with Relapsed or Refractory CD19+ Lymphomas

DeepDyve requires Javascript to function. Please enable Javascript on your browser to continue.

Schuster, Stephen J.; Svoboda, Jakub; Dwivedy Nasta, Sunita; Porter, David L.; Chong, Elise A.;

Blood – Dec 3, 2015

Download PDF

Schuster, Stephen J.; Svoboda, Jakub; Dwivedy Nasta, Sunita; Porter, David L.; Chong, Elise A.;

Blood – Dec 3, 2015

Loading next page...

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.